Complete Guide to Semaglutide Pharmacokinetics
Overview
Semaglutide is a GLP-1 RA used in the Metabolic therapeutic area. It is indicated for Type 2 Diabetes / Obesity. Interactive pharmacokinetic simulator for semaglutide (Ozempic/Wegovy). Explore weekly dosing and steady-state concentrations.
Mechanism of Action
Semaglutide exerts its pharmacological effect by targeting GLP-1R. As a GLP-1 RA, it modulates this target to achieve therapeutic efficacy in Type 2 Diabetes / Obesity. Understanding the target engagement is critical for interpreting the pharmacokinetic-pharmacodynamic (PK/PD) relationship and optimizing dosing regimens.
Key Pharmacokinetic Parameters
The following parameters are derived from published PK/PD models for Semaglutide:
| Parameter | Value |
|---|---|
| CL | 0.05 L/h |
| Vd | 12.5 L |
| ka | 0.0078 h⁻¹ |
| CL F | 0.035 L/h |
| Tmax | 24-36 h |
| Vc F | 7.38 L |
| IIV CL | 20% CV |
| t half | ~168 h (1 week) |
| dose SC | 0.25-2.4 mg weekly |
| protein binding | >99% (albumin) |
| bioavailability SC | 0.89 |
| bioavailability oral | ~0.01 |
Parameters represent typical population estimates from published literature. Individual values may vary.
Dosing & Administration
Semaglutide is administered via the SC route. Subcutaneous administration provides sustained absorption from the injection site. Bioavailability and absorption rate may vary by injection site and volume.
Dosing recommendations should always follow approved prescribing information. The interactive simulator allows you to explore different dosing scenarios and their impact on drug exposure metrics such as AUC, Cmax, and Ctrough.
Clinical Considerations
In the Metabolic therapeutic area, for the treatment of Type 2 Diabetes / Obesity, understanding the pharmacokinetics of Semaglutide is essential for dose optimization and therapeutic drug monitoring. Key clinical factors that may affect Semaglutide pharmacokinetics include:
- •Body weight and body composition
- •Renal and hepatic function
- •Drug-drug interactions and concomitant medications
- •Age, sex, and genetic polymorphisms
Interactive Semaglutide PK Simulator
Explore Semaglutide pharmacokinetics interactively. Adjust doses, dosing intervals, and patient covariates to visualize concentration-time profiles in real time.
Frequently Asked Questions
What is the half-life of Semaglutide?
The elimination half-life of Semaglutide depends on patient-specific factors. Based on published models, the typical half-life is approximately ~168 h (1 week).
How is Semaglutide administered?
Semaglutide is administered via the SC route. It is indicated for Type 2 Diabetes / Obesity. As a GLP-1 RA, dosing regimens should follow approved prescribing information and clinical guidelines.
What are the key PK parameters of Semaglutide?
Key pharmacokinetic parameters for Semaglutide include clearance (CL), volume of distribution (Vd), and elimination half-life. See the PK Parameters section above for specific values from published models.
Can I simulate Semaglutide dosing scenarios for free?
Yes! PKPDBuilder offers a completely free, interactive Semaglutide PK simulator based on published pharmacometric models. No login required. Use it to explore different doses, dosing intervals, and patient covariates.
⚠️ Disclaimer
This guide is for research and educational purposes only. It is not intended for clinical decision-making or patient dosing. Parameters are derived from published literature and represent population estimates. Always consult approved prescribing information for clinical use.